Crossroads of L-Arginine/Arachidonate Metabolism

• References

• 1 Gryglewski RJ, Chlopicki S, Swiês J, Niezabitowski P. Prostacyclin, nitric oxide and atherosclerosis. Ann NY Acad Sci 1995; 748: 195-207
• 2 Giyglewski RJ. Interactions between endothelial secretogogues. Ann Med 1995; 27: 421-427
• 3 Wizemann TM, Gardner CR, Laskin JD, Quinones S, Durham SK, Goller NL, Ohnishi ST, Laskin DL. Production of nitric oxide and peroxynitrite in the lung during acute endotoxemia. J Leukocyte Biol 1994; 56: 759-768
• 4 Kooy NW, Royall JA, Ye YZ, Kelly DR, Beckman JS. Evidence for in vivo peroxynitrite production in human acute lung injury. Am J Respirat Crit Care Med 1995; 151: 1250-1254
• 5 Szabó C, Zingarelli B, O’Connor M, Salzman AL. DNA strand breakage, activation of poly(ADP-ribose) synthetase, and cellular energy depletion are involved in the cytotoxicity in macrophages and smooth muscle cells exposed to peroxynitrite. Proc Nat Acad Sci USA 1996; 93: 1753-1758
• 6 Radi R, Beckman JS, Bush KM, Freeman BA. Peroxynitrite-induced membrane lipid peroxidation: The cytotoxic potential of superoxide and nitric oxide. Arch Biochem Biophys 1991; 288: 481-487
• 7 Phelps DT, Ferro TJ, Higgins PJ, Shankar R, Parker DM, Johnson A. TNF-induces peroxynitrite-mediated depletion of lung endothelial glutathione via protein kinase C. Am J Physiol 1995; 269: L551-L559
• 8 Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328: 309-316
• 9 Mayer B, Schrammel A, Klatt P, Koesling D, Schmidt K. Peroxy-nitrite-induced accumulation of cyclic GMP in endothelial cells and stimulation of purified soluble guanylate cyclase. Dependence on glutathione and possible role of S-nitrosation. J Biol Chem 1995; 270: 17355-17360
• 10 Kanner J, Harel S, Granit R. Nitric oxide an inhibitor of lipid oxidation by lipoxygenase, cyclooxygenase and hemoglobin. Lipids 1992; 27: 46-49
• 11 Zou M-H, Ullrich V. Peroxinitrite formed by simultaneous generation of nitric oxide and superoxide selectively inhibits bovine prostacyclin synthase. FEBS Lett 1996; 382: 101-104
• 12 Salvemini D, Misko TP, Masferrer L, Seibert K, Currie MG, Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 1993; 90: 7240-7244
• 13 Marotta P, Sautebin L, Di RosaM. Modulation of the induction of nitric oxide synthase by eicosanoid in the murine macrophage cell line J774 cells. Br J Pharmacol 1992; 107: 640-641
• 14 Stamler JS, Vaughan DE, Loscalzo J. Synergistic disaggregation of platelets by tissue-type plasminogen activator, prostaglandin Ej and nitroglycerin. Circ Res 1989; 65: 796-804
• 15 Bieroń K, Grodzińska L, Kostka-Trabka E, Gryglewski RJ. Prostacyclin and molsidomine synergise in their fibrinolytic and anti-platelet actions in patients with perpheral arterial disease. Wien Klin Wochenschr 1993; 105: 07-11
• 16 Chlopicki S, Gryglewski RJ. Nitric oxide is a major mediator in reactive hyperaemia evoked by a brief coronary occlusion in the guinea pig heart. Eur J Pharmacol 1993; 241: 117-120
• 17 Szczeklik A, Giyglewski RJ. Low-density lipoproteins (LDL) are carriers for lipid peroxides and invalidate prostacyclin (PGI2) biosynthesis in arteries. Artery 1980; 07: 488-492
• 18 Yang X, Cai B, Sciacca RR, Cannon JP. Inhibition of inducible nitric oxide synthase in macrophages by oxidized low-density lipoproteins. Cir Res 1994; 74: 318-328
• 19 Gilligan DM, Guetta V, Panza JA, Garcia CE, Quyyumi AA, Cannon RO. Selective loss of microvascular endothelial function in human hypercholesterolemia. Circulation 1994; 90: 35-44
• 20 Hogg N, Kalyanaraman B, Joseph J, Struck A, Parthasarathy S. Inhibition of low-density lipoprotein oxidation by nitric oxide. FEBS Lett 1993; 334: 170-174
• 21 Parratt JR. An introduction and an overview. In Schlag G, Redl H. (eds) Nitric Oxide and Cardiovascular Dysfunction in Sepsis and Endotoxaemia. Springer Verlag; Belin, Heidelberg, New York: 1995: 01-29
• 22 Szabó C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischaemia-reperfusion injury. Shock 1996; 06: 01-10
• 23 Wang WW, Jenkinson CP, Griscawage JM, Kern RM, Arabolos NS, Byrns RE, Cederbaum SD, Ignarro LJ. Co-induction of arginase and nitric oxide synthase in murine macrophages activated by lipopolysaccharide. Biochem Biophys Res Commun 1995; 210: 1009-1016
• 24 Kilboum RG, Jubran A, Gross SS, Griffith OW, Levi R, Adams J, Lodato RF. Reversal of endotoxin-mediated shock by N^G-methyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 1990; 172: 1132-1138
• 25 Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 1994; 28: 34-39
• 26 Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg 1994; 129: 142-147
• 27 Pastor C, Teisseire B, Vicaut E, Payen D. Effects of L-arginine and L-nitro-arginine treatment on blood pressure and cardiac output in a rabbit endotoxin shock model. Crit Care Med 1994; 22: 465-469
• 28 Mulder MF, van LambalgenAA, Huisnab E, Visser JJ, and den BosGC, Thijs LG. Protective role of NO in the regional hemodynamic changes during acute endotoxemia in rats. Am J Physiol 1994; 266: H1558-H1564
• 29 Statman R, Cheng W, Cunningham JN, Henderson JL, Damiani P, Siconolfi A, Rogers D, Horovitz JK. Nitric oxide inhibition in the treatment of the sepsis syndrome is detrimental to tissue oxygenataion. J Surg Res 1994; 57: 93-98
• 30 Hutcheson IR, Whittle BJ, Boughton SmithNK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 815-820
• 31 Shultz PJ, Raij L. Endogenously synthetized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992; 90: 1718-1725
• 32 Harbrecht BG, Stadler J, Demetris AJ, Simmons RL, Billar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994; 266: G1004-G1010
• 33 Szabó C, Southan GJ, Thiemermann C. Beneficial effects and improved survival in rodent models of septic shock with S-methylisothiourea sulfate, a potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 1994; 91: 12472-12476
• 34 Malinski T, Czuchajowski L. Nitric oxide measurement by electro-chemical methods. In Feelisch M, Stamler JS. (eds) Methods of Nitric Oxide Research Wiley, Chichester: 1996: 319-339
• 35 Gryglewski RJ, Szczeklik A, Korbut R, Swies J, Musial J, Krzanowski M, Maga P. The mechanism of anti-thrombotic, thrombolytic and fibrinolytic actions of camonagrel — a new thromboxane synthase inhibitor. Wien Klin Wochenschr 1995; 107: 283-289
• 36 Casals-Stenzel J. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock. Eur J Pharmacol 1987; 135: 117-122
• 37 Gryglewski RJ, Wolkow PP, Uracz W, Janowska E, Bartus JB, Balbatun O, Hatrik S, Patton S, Malinski T. Protective role of pulmonary nitric oxide in acute phase of endotoxaemia in rats. In preparation
• 38 Rossoni G, Sala A, Berti F, Testa T, Buccelati C, Molta C, Müller-Pedinghaus R, Maclouf J, Folco G. Myocardial protection by the leukotriene synthesis inhibitor BAY X 1005: importance of transcellular biosynthesis of cysteinyl-leukotriens. J Pharm Exp Ther 1996; 276: 335-341
• 39 Uhlig S, Wolin L, Wendel A. Contributions of thromboxane and leukotrienes to PAF-induced impairment of lung function in the rat. J Appl Physiol 1994; 77: 262-269